MedTrace Logo

A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization

NCT00465101 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2015-10-28

Study results available
· View outcomes & findings →

Summary

To gain clinical experience with the GreenLight HPS System, a system designed to vaporize and coagulate tissue in the treatment of benign prostatic hyperplasia to reduce lower urinary tract symptoms.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DEVICE

GreenLight HPS

Greenlight HPS laser system for treatment of BPH

Sponsors & Collaborators

  • American Medical Systems

    lead INDUSTRY

Principal Investigators

  • Claus G Roehrborn, MD · UT Southwestern Medical Center at Dallas

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2012-08-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00465101 on ClinicalTrials.gov